Covid-19 Impact on Global Hemato Oncology Testing Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-hemato-oncology-testing-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Hemato Oncology Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemato Oncology Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- F. Hoffmann-La Roche
- Abbott Laboratories
- Thermo Fisher Scientific
- QIAGEN N.V.
- Bio-Rad Laboratories
- Illumina
- MolecularMD
- Invivoscribe
- Asuragen
- Adaptive Biotechnologies
- ArcherDx
- ARUP Laboratories
- Leukemia Testing
- Acute Myeloid Testing
- Multiple Myeloma Testing
- Other
- Clinical Laboratories
- Hospitals
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Hemato Oncology Testing status, future forecast, growth opportunity, key market and key players.
- To present the Hemato Oncology Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Leukemia Testing
1.4.3 Acute Myeloid Testing
1.4.4 Multiple Myeloma Testing
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
1.5.2 Clinical Laboratories
1.5.3 Hospitals
1.6 Coronavirus Disease 2019 (Covid-19): Hemato Oncology Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemato Oncology Testing Industry
1.6.1.1 Hemato Oncology Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemato Oncology Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemato Oncology Testing Market Perspective (2015-2026)
2.2 Hemato Oncology Testing Growth Trends by Regions
2.2.1 Hemato Oncology Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemato Oncology Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hemato Oncology Testing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemato Oncology Testing Players by Market Size
3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2015-2020)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemato Oncology Testing Market Concentration Ratio
3.2.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2019
3.3 Hemato Oncology Testing Key Players Head office and Area Served
3.4 Key Players Hemato Oncology Testing Product Solution and Service
3.5 Date of Enter into Hemato Oncology Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemato Oncology Testing Historic Market Size by Type (2015-2020)
4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2021-2026)
5 HEMATO ONCOLOGY TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemato Oncology Testing Market Size by Application (2015-2020)
5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemato Oncology Testing Market Size (2015-2020)
6.2 Hemato Oncology Testing Key Players in North America (2019-2020)
6.3 North America Hemato Oncology Testing Market Size by Type (2015-2020)
6.4 North America Hemato Oncology Testing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemato Oncology Testing Market Size (2015-2020)
7.2 Hemato Oncology Testing Key Players in Europe (2019-2020)
7.3 Europe Hemato Oncology Testing Market Size by Type (2015-2020)
7.4 Europe Hemato Oncology Testing Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemato Oncology Testing Market Size (2015-2020)
8.2 Hemato Oncology Testing Key Players in China (2019-2020)
8.3 China Hemato Oncology Testing Market Size by Type (2015-2020)
8.4 China Hemato Oncology Testing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemato Oncology Testing Market Size (2015-2020)
9.2 Hemato Oncology Testing Key Players in Japan (2019-2020)
9.3 Japan Hemato Oncology Testing Market Size by Type (2015-2020)
9.4 Japan Hemato Oncology Testing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemato Oncology Testing Market Size (2015-2020)
10.2 Hemato Oncology Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemato Oncology Testing Market Size (2015-2020)
11.2 Hemato Oncology Testing Key Players in India (2019-2020)
11.3 India Hemato Oncology Testing Market Size by Type (2015-2020)
11.4 India Hemato Oncology Testing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemato Oncology Testing Market Size (2015-2020)
12.2 Hemato Oncology Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemato Oncology Testing Market Size by Type (2015-2020)
12.4 Central & South America Hemato Oncology Testing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Hemato Oncology Testing Introduction
13.1.4 F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview and Its Total Revenue
13.2.3 Abbott Laboratories Hemato Oncology Testing Introduction
13.2.4 Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Hemato Oncology Testing Introduction
13.3.4 Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 QIAGEN N.V.
13.4.1 QIAGEN N.V. Company Details
13.4.2 QIAGEN N.V. Business Overview and Its Total Revenue
13.4.3 QIAGEN N.V. Hemato Oncology Testing Introduction
13.4.4 QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020)
13.4.5 QIAGEN N.V. Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.5.3 Bio-Rad Laboratories Hemato Oncology Testing Introduction
13.5.4 Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Illumina
13.6.1 Illumina Company Details
13.6.2 Illumina Business Overview and Its Total Revenue
13.6.3 Illumina Hemato Oncology Testing Introduction
13.6.4 Illumina Revenue in Hemato Oncology Testing Business (2015-2020)
13.6.5 Illumina Recent Development
13.7 MolecularMD
13.7.1 MolecularMD Company Details
13.7.2 MolecularMD Business Overview and Its Total Revenue
13.7.3 MolecularMD Hemato Oncology Testing Introduction
13.7.4 MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020)
13.7.5 MolecularMD Recent Development
13.8 Invivoscribe
13.8.1 Invivoscribe Company Details
13.8.2 Invivoscribe Business Overview and Its Total Revenue
13.8.3 Invivoscribe Hemato Oncology Testing Introduction
13.8.4 Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020)
13.8.5 Invivoscribe Recent Development
13.9 Asuragen
13.9.1 Asuragen Company Details
13.9.2 Asuragen Business Overview and Its Total Revenue
13.9.3 Asuragen Hemato Oncology Testing Introduction
13.9.4 Asuragen Revenue in Hemato Oncology Testing Business (2015-2020)
13.9.5 Asuragen Recent Development
13.10 Adaptive Biotechnologies
13.10.1 Adaptive Biotechnologies Company Details
13.10.2 Adaptive Biotechnologies Business Overview and Its Total Revenue
13.10.3 Adaptive Biotechnologies Hemato Oncology Testing Introduction
13.10.4 Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020)
13.10.5 Adaptive Biotechnologies Recent Development
13.11 ArcherDx
10.11.1 ArcherDx Company Details
10.11.2 ArcherDx Business Overview and Its Total Revenue
10.11.3 ArcherDx Hemato Oncology Testing Introduction
10.11.4 ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020)
10.11.5 ArcherDx Recent Development
13.12 ARUP Laboratories
10.12.1 ARUP Laboratories Company Details
10.12.2 ARUP Laboratories Business Overview and Its Total Revenue
10.12.3 ARUP Laboratories Hemato Oncology Testing Introduction
10.12.4 ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
10.12.5 ARUP Laboratories Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Leukemia Testing
1.4.3 Acute Myeloid Testing
1.4.4 Multiple Myeloma Testing
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
1.5.2 Clinical Laboratories
1.5.3 Hospitals
1.6 Coronavirus Disease 2019 (Covid-19): Hemato Oncology Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemato Oncology Testing Industry
1.6.1.1 Hemato Oncology Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemato Oncology Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemato Oncology Testing Market Perspective (2015-2026)
2.2 Hemato Oncology Testing Growth Trends by Regions
2.2.1 Hemato Oncology Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemato Oncology Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hemato Oncology Testing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemato Oncology Testing Players by Market Size
3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2015-2020)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemato Oncology Testing Market Concentration Ratio
3.2.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2019
3.3 Hemato Oncology Testing Key Players Head office and Area Served
3.4 Key Players Hemato Oncology Testing Product Solution and Service
3.5 Date of Enter into Hemato Oncology Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemato Oncology Testing Historic Market Size by Type (2015-2020)
4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2021-2026)
5 HEMATO ONCOLOGY TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemato Oncology Testing Market Size by Application (2015-2020)
5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemato Oncology Testing Market Size (2015-2020)
6.2 Hemato Oncology Testing Key Players in North America (2019-2020)
6.3 North America Hemato Oncology Testing Market Size by Type (2015-2020)
6.4 North America Hemato Oncology Testing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemato Oncology Testing Market Size (2015-2020)
7.2 Hemato Oncology Testing Key Players in Europe (2019-2020)
7.3 Europe Hemato Oncology Testing Market Size by Type (2015-2020)
7.4 Europe Hemato Oncology Testing Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemato Oncology Testing Market Size (2015-2020)
8.2 Hemato Oncology Testing Key Players in China (2019-2020)
8.3 China Hemato Oncology Testing Market Size by Type (2015-2020)
8.4 China Hemato Oncology Testing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemato Oncology Testing Market Size (2015-2020)
9.2 Hemato Oncology Testing Key Players in Japan (2019-2020)
9.3 Japan Hemato Oncology Testing Market Size by Type (2015-2020)
9.4 Japan Hemato Oncology Testing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemato Oncology Testing Market Size (2015-2020)
10.2 Hemato Oncology Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemato Oncology Testing Market Size (2015-2020)
11.2 Hemato Oncology Testing Key Players in India (2019-2020)
11.3 India Hemato Oncology Testing Market Size by Type (2015-2020)
11.4 India Hemato Oncology Testing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemato Oncology Testing Market Size (2015-2020)
12.2 Hemato Oncology Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemato Oncology Testing Market Size by Type (2015-2020)
12.4 Central & South America Hemato Oncology Testing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Hemato Oncology Testing Introduction
13.1.4 F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview and Its Total Revenue
13.2.3 Abbott Laboratories Hemato Oncology Testing Introduction
13.2.4 Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Hemato Oncology Testing Introduction
13.3.4 Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 QIAGEN N.V.
13.4.1 QIAGEN N.V. Company Details
13.4.2 QIAGEN N.V. Business Overview and Its Total Revenue
13.4.3 QIAGEN N.V. Hemato Oncology Testing Introduction
13.4.4 QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020)
13.4.5 QIAGEN N.V. Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.5.3 Bio-Rad Laboratories Hemato Oncology Testing Introduction
13.5.4 Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Illumina
13.6.1 Illumina Company Details
13.6.2 Illumina Business Overview and Its Total Revenue
13.6.3 Illumina Hemato Oncology Testing Introduction
13.6.4 Illumina Revenue in Hemato Oncology Testing Business (2015-2020)
13.6.5 Illumina Recent Development
13.7 MolecularMD
13.7.1 MolecularMD Company Details
13.7.2 MolecularMD Business Overview and Its Total Revenue
13.7.3 MolecularMD Hemato Oncology Testing Introduction
13.7.4 MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020)
13.7.5 MolecularMD Recent Development
13.8 Invivoscribe
13.8.1 Invivoscribe Company Details
13.8.2 Invivoscribe Business Overview and Its Total Revenue
13.8.3 Invivoscribe Hemato Oncology Testing Introduction
13.8.4 Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020)
13.8.5 Invivoscribe Recent Development
13.9 Asuragen
13.9.1 Asuragen Company Details
13.9.2 Asuragen Business Overview and Its Total Revenue
13.9.3 Asuragen Hemato Oncology Testing Introduction
13.9.4 Asuragen Revenue in Hemato Oncology Testing Business (2015-2020)
13.9.5 Asuragen Recent Development
13.10 Adaptive Biotechnologies
13.10.1 Adaptive Biotechnologies Company Details
13.10.2 Adaptive Biotechnologies Business Overview and Its Total Revenue
13.10.3 Adaptive Biotechnologies Hemato Oncology Testing Introduction
13.10.4 Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020)
13.10.5 Adaptive Biotechnologies Recent Development
13.11 ArcherDx
10.11.1 ArcherDx Company Details
10.11.2 ArcherDx Business Overview and Its Total Revenue
10.11.3 ArcherDx Hemato Oncology Testing Introduction
10.11.4 ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020)
10.11.5 ArcherDx Recent Development
13.12 ARUP Laboratories
10.12.1 ARUP Laboratories Company Details
10.12.2 ARUP Laboratories Business Overview and Its Total Revenue
10.12.3 ARUP Laboratories Hemato Oncology Testing Introduction
10.12.4 ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
10.12.5 ARUP Laboratories Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Hemato Oncology Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Hemato Oncology Testing Revenue
Table 3. Ranking of Global Top Hemato Oncology Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Leukemia Testing
Table 6. Key Players of Acute Myeloid Testing
Table 7. Key Players of Multiple Myeloma Testing
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Hemato Oncology Testing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemato Oncology Testing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
Table 14. Global Hemato Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemato Oncology Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemato Oncology Testing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Regions (2015-2020)
Table 18. Global Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemato Oncology Testing Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemato Oncology Testing Players
Table 25. Global Hemato Oncology Testing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemato Oncology Testing Market Share by Players (2015-2020)
Table 27. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019)
Table 28. Global Hemato Oncology Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemato Oncology Testing Product Solution and Service
Table 31. Date of Enter into Hemato Oncology Testing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemato Oncology Testing Market Size Share by Type (2015-2020)
Table 35. Global Hemato Oncology Testing Revenue Market Share by Type (2021-2026)
Table 36. Global Hemato Oncology Testing Market Size Share by Application (2015-2020)
Table 37. Global Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemato Oncology Testing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 41. North America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 43. North America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 47. Europe Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemato Oncology Testing Market Share by Type (2015-2020)
Table 49. Europe Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemato Oncology Testing Market Share by Application (2015-2020)
Table 51. China Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 53. China Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemato Oncology Testing Market Share by Type (2015-2020)
Table 55. China Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemato Oncology Testing Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 59. Japan Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemato Oncology Testing Market Share by Type (2015-2020)
Table 61. Japan Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemato Oncology Testing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 65. Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemato Oncology Testing Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemato Oncology Testing Market Share by Application (2015-2020)
Table 69. India Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 71. India Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemato Oncology Testing Market Share by Type (2015-2020)
Table 73. India Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemato Oncology Testing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 77. Central & South America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 79. Central & South America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Product
Table 84. F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Abbott Laboratories Company Details
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Product
Table 89. Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 90. Abbott Laboratories Recent Development
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Product
Table 94. Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 95. Thermo Fisher Scientific Recent Development
Table 96. QIAGEN N.V. Company Details
Table 97. QIAGEN N.V. Business Overview
Table 98. QIAGEN N.V. Product
Table 99. QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 100. QIAGEN N.V. Recent Development
Table 101. Bio-Rad Laboratories Company Details
Table 102. Bio-Rad Laboratories Business Overview
Table 103. Bio-Rad Laboratories Product
Table 104. Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 105. Bio-Rad Laboratories Recent Development
Table 106. Illumina Company Details
Table 107. Illumina Business Overview
Table 108. Illumina Product
Table 109. Illumina Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 110. Illumina Recent Development
Table 111. MolecularMD Company Details
Table 112. MolecularMD Business Overview
Table 113. MolecularMD Product
Table 114. MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 115. MolecularMD Recent Development
Table 116. Invivoscribe Business Overview
Table 117. Invivoscribe Product
Table 118. Invivoscribe Company Details
Table 119. Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 120. Invivoscribe Recent Development
Table 121. Asuragen Company Details
Table 122. Asuragen Business Overview
Table 123. Asuragen Product
Table 124. Asuragen Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 125. Asuragen Recent Development
Table 126. Adaptive Biotechnologies Company Details
Table 127. Adaptive Biotechnologies Business Overview
Table 128. Adaptive Biotechnologies Product
Table 129. Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 130. Adaptive Biotechnologies Recent Development
Table 131. ArcherDx Company Details
Table 132. ArcherDx Business Overview
Table 133. ArcherDx Product
Table 134. ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 135. ArcherDx Recent Development
Table 136. ARUP Laboratories Company Details
Table 137. ARUP Laboratories Business Overview
Table 138. ARUP Laboratories Product
Table 139. ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 140. ARUP Laboratories Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 1. Hemato Oncology Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Hemato Oncology Testing Revenue
Table 3. Ranking of Global Top Hemato Oncology Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Leukemia Testing
Table 6. Key Players of Acute Myeloid Testing
Table 7. Key Players of Multiple Myeloma Testing
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Hemato Oncology Testing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemato Oncology Testing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
Table 14. Global Hemato Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemato Oncology Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemato Oncology Testing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Regions (2015-2020)
Table 18. Global Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemato Oncology Testing Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemato Oncology Testing Players
Table 25. Global Hemato Oncology Testing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemato Oncology Testing Market Share by Players (2015-2020)
Table 27. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019)
Table 28. Global Hemato Oncology Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemato Oncology Testing Product Solution and Service
Table 31. Date of Enter into Hemato Oncology Testing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemato Oncology Testing Market Size Share by Type (2015-2020)
Table 35. Global Hemato Oncology Testing Revenue Market Share by Type (2021-2026)
Table 36. Global Hemato Oncology Testing Market Size Share by Application (2015-2020)
Table 37. Global Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemato Oncology Testing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 41. North America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 43. North America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 47. Europe Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemato Oncology Testing Market Share by Type (2015-2020)
Table 49. Europe Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemato Oncology Testing Market Share by Application (2015-2020)
Table 51. China Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 53. China Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemato Oncology Testing Market Share by Type (2015-2020)
Table 55. China Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemato Oncology Testing Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 59. Japan Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemato Oncology Testing Market Share by Type (2015-2020)
Table 61. Japan Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemato Oncology Testing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 65. Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemato Oncology Testing Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemato Oncology Testing Market Share by Application (2015-2020)
Table 69. India Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 71. India Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemato Oncology Testing Market Share by Type (2015-2020)
Table 73. India Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemato Oncology Testing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 77. Central & South America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 79. Central & South America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Product
Table 84. F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Abbott Laboratories Company Details
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Product
Table 89. Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 90. Abbott Laboratories Recent Development
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Product
Table 94. Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 95. Thermo Fisher Scientific Recent Development
Table 96. QIAGEN N.V. Company Details
Table 97. QIAGEN N.V. Business Overview
Table 98. QIAGEN N.V. Product
Table 99. QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 100. QIAGEN N.V. Recent Development
Table 101. Bio-Rad Laboratories Company Details
Table 102. Bio-Rad Laboratories Business Overview
Table 103. Bio-Rad Laboratories Product
Table 104. Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 105. Bio-Rad Laboratories Recent Development
Table 106. Illumina Company Details
Table 107. Illumina Business Overview
Table 108. Illumina Product
Table 109. Illumina Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 110. Illumina Recent Development
Table 111. MolecularMD Company Details
Table 112. MolecularMD Business Overview
Table 113. MolecularMD Product
Table 114. MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 115. MolecularMD Recent Development
Table 116. Invivoscribe Business Overview
Table 117. Invivoscribe Product
Table 118. Invivoscribe Company Details
Table 119. Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 120. Invivoscribe Recent Development
Table 121. Asuragen Company Details
Table 122. Asuragen Business Overview
Table 123. Asuragen Product
Table 124. Asuragen Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 125. Asuragen Recent Development
Table 126. Adaptive Biotechnologies Company Details
Table 127. Adaptive Biotechnologies Business Overview
Table 128. Adaptive Biotechnologies Product
Table 129. Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 130. Adaptive Biotechnologies Recent Development
Table 131. ArcherDx Company Details
Table 132. ArcherDx Business Overview
Table 133. ArcherDx Product
Table 134. ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 135. ArcherDx Recent Development
Table 136. ARUP Laboratories Company Details
Table 137. ARUP Laboratories Business Overview
Table 138. ARUP Laboratories Product
Table 139. ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 140. ARUP Laboratories Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Hemato Oncology Testing Market Share by Type: 2020 VS 2026
Figure 2. Leukemia Testing Features
Figure 3. Acute Myeloid Testing Features
Figure 4. Multiple Myeloma Testing Features
Figure 5. Other Features
Figure 6. Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
Figure 7. Clinical Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Hemato Oncology Testing Report Years Considered
Figure 10. Global Hemato Oncology Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemato Oncology Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemato Oncology Testing Market Share by Players in 2019
Figure 15. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2019
Figure 17. North America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. F. Hoffmann-La Roche Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Thermo Fisher Scientific Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 30. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. QIAGEN N.V. Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 32. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bio-Rad Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 34. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Illumina Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 36. MolecularMD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MolecularMD Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 38. Invivoscribe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Invivoscribe Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 40. Asuragen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Asuragen Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 42. Adaptive Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Adaptive Biotechnologies Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 44. ArcherDx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. ArcherDx Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 46. ARUP Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ARUP Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Figure 1. Global Hemato Oncology Testing Market Share by Type: 2020 VS 2026
Figure 2. Leukemia Testing Features
Figure 3. Acute Myeloid Testing Features
Figure 4. Multiple Myeloma Testing Features
Figure 5. Other Features
Figure 6. Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
Figure 7. Clinical Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Hemato Oncology Testing Report Years Considered
Figure 10. Global Hemato Oncology Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemato Oncology Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemato Oncology Testing Market Share by Players in 2019
Figure 15. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2019
Figure 17. North America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. F. Hoffmann-La Roche Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Thermo Fisher Scientific Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 30. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. QIAGEN N.V. Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 32. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bio-Rad Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 34. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Illumina Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 36. MolecularMD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MolecularMD Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 38. Invivoscribe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Invivoscribe Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 40. Asuragen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Asuragen Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 42. Adaptive Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Adaptive Biotechnologies Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 44. ArcherDx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. ArcherDx Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 46. ARUP Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ARUP Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed